Coagulation factors are protein components of the blood which serve blood coagulation.
Search results 26 to 50 from a total of 89
| Name | Marketing Authorisation Holder | License Number | License Date | Further Information |
|---|---|---|---|---|
|
Faktor VIII SDH INTERSERO 500 |
Intersero GmbH |
16844.01.00 | 06.11.1991 | |
|
Faktor VIII SDH INTERSERO 1000 |
Intersero GmbH |
16844.02.00 | 06.11.1991 | |
|
Fanhdi 250 I.E. |
Grifols Deutschland GmbH |
10565a/97-1 | 12.08.1999 | |
|
Fanhdi 500 I.E. |
Grifols Deutschland GmbH |
10565a/97-2 | 12.08.1999 | |
|
Fanhdi 1000 I.E. |
Grifols Deutschland GmbH |
10565a/97-3 | 12.08.1999 | |
|
Fanhdi 1500 I.E. |
Grifols Deutschland GmbH |
PEI.H.03436.01.1 | 24.08.2006 | |
|
FibCLOT |
Laboratoire Français du Fractionnement et des Biotechnologies, F Les Ulis |
PEI.H.11771.01.1 | 05.02.2016 | |
|
Fibrogammin 250 |
CSL Behring GmbH |
PEI.H.03242.01.1 | 07.02.2005 | |
|
Fibrogammin 1250 |
CLS Behring GmbH |
PEI.H.03242.02.1 | 07.02.2005 | |
|
Fibryga |
Octapharma GmbH |
PEI.H.11879.01.1 | 23.06.2017 | |
|
Haemate P 250 I.E. FVIII / 600 I.E. VWF |
CSL Behring GmbH |
2416.00.00 | 08.06.1982 | |
|
Haemate P 500 I.E. FVIII / 1200 I.E. VWF |
CSL Behring GmbH |
2416.01.00 | 08.06.1982 | |
|
Haemate P 1000 I.E. FVIII / 2400 I.E. VWF |
CSL Behring GmbH |
2416.02.00 | 08.06.1982 | |
Haemate P 1000 I.E. FVIII / 2400 I.E. VWF |
Orifarm GmbH |
PEI.H.12082.01.1 | 24.03.2021 | |
Haemate P 1000 I.E. FVIII / 2400 I.E. VWF |
kohlpharma GmbH |
PEI.H.12140.01.1 | 14.02.2022 | |
|
Haemocomplettan P 1g |
CSL Behring GmbH |
PEI.H.03265.01.1 | 22.03.2005 | Rote-Hand-Brief: Haemocomplettan und Riastap (01.04.2019) |
|
Haemocomplettan P 2g |
CSL Behring GmbH |
PEI.H.03265.02.1 | 22.03.2005 | Rote-Hand-Brief: Haemocomplettan und Riastap (01.04.2019) |
|
Haemoctin SDH 250 |
Biotest Pharma GmbH |
16841.00.00 | 06.11.1991 | |
|
Haemoctin SDH 500 |
Biotest Pharma GmbH |
16841.01.00 | 06.11.1991 | |
|
Haemoctin SDH 1000 |
Biotest Pharma GmbH |
16841.02.00 | 06.11.1991 | |
Haemoctin SDH 1000 |
EurimPharm Arzneimittel GmbH |
PEI.H.12119.01.1 | 26.08.2021 | |
|
Haemonine 500 |
Biotest Pharma GmbH |
PEI.H.03626.02.1 | 02.01.2009 | |
|
Haemonine 1000 |
Biotest Pharma GmbH |
PEI.H.03626.03.1 | 02.01.2009 | |
|
Idelvion |
CSL Behring GmbH |
EU/1/16/1095 | 11.05.2016 | |
|
IMMUNATE 500 I.E. |
Takeda GmbH |
3854.02.00 | 20.10.1983 |
The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.
The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.
As of: PEI announcement No. 519 in BAnz AT 26.07.2024 B6.
Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.
If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.
Updated: 26.07.2024
